Advertisment
 

Join the Topix community today: 

Sign Up

 | 

Sign In

updated: Thu Jul 03, 2008 11:56 am

Amylin Pharmaceuticals News

News on Amylin Pharmaceuticals continually updated from thousands of sources around the net.

Thursday Jul 3 | A Library Writer's Blog

CFP: San Diego Chapter of Special Libraries Association

CFP: San Diego Chapter of Special Libraries Association SLA-SD Fall Seminar Call for Speakers The San Diego Chapter of the Special Libraries Association is seeking speakers for our annual full-day professional ...

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Libraries, Internet, Science / Technology

Tue Jun 24, 2008

Seeking Alpha

Amylin Has Yet to Crack Tough Diabetes Market

Diabetes is a tough market to compete in for any company. Insulin is the standard therapy for most patients with severe Diabetes.

Comment?

Related Topix: Medicine, Diabetes, Health, Biotech, Healthcare Industry, Insulin (generic), Humulin, Novolin, Medication

Wed Jun 18, 2008

Indianapolis Star

Who is this guy? And does Eli Lilly need to be afraid of him?

Corporate raider Carl Icahn has a long history of shaking up companies. Now the 72-year-old billionaire has grabbed a $200 million stake in Amylin Pharmaceuticals, Lilly's partner in the diabetes drug Byetta.

Comment?

Related Topix: Blockbuster, Medicine, Diabetes, Health, Biotech, Eli Lilly, Healthcare Industry

Mon Jun 16, 2008

Market Watch

Amylin, Liily, Alkermes report progress with diabetes drug

Amylin Pharmaceuticals Inc., Eli Lilly & Co., and Alkermes Inc. reported progress with once-weekly Byetta, generically, exenatide, an adjunct treatment for type-2-diabetes patients who are taking metformin but ...

Comment?

Related Topix: Medicine, Diabetes, Health, Biotech, Eli Lilly, Healthcare Industry, Alkermes, Metformin (generic), Glucophage, Medication

Sat Jun 14, 2008

BioSpace

Amylin Pharmaceuticals, Inc. Weekly Diabetes Drug Lowers Blood Sugar

Amylin Pharmaceuticals, Inc. , Eli Lilly and Company , and Alkermes, Inc. today announced results from a 52-week open label clinical study that showed the durable efficacy of exenatide once weekly, a ...

Comment?

Related Topix: Biotech, Eli Lilly, Healthcare Industry, North Carolina, Alkermes

Thu Jun 12, 2008

International Business Times

Amylin falls as Byetta and Exenatide concerns grow

Amylin Pharmaceuticals Inc. shares tumbled Monday on threats to the company's diabetes drug Byetta and its longer-lasting drug candidate Exenatide LAR.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Diabetes, Health

Tue Jun 10, 2008

Market Watch

Drug stocks dip; Amylin rebounds on Byetta study

Drug stocks slipped in early action Tuesday as shares of Amylin Pharmaceuticals were on the rebound after releasing a favorable study on the effectiveness of a long-acting version of its diabetes drug Byetta, ...

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Mon Jun 09, 2008

MarketWatch

Biotech Stocks: Amylin leads drug stocks lower

Drug stocks moved lower in early trading Monday as shares of Amylin Pharmaceuticals fell on concerns that its diabetes drug Byetta could soon be facing competition from a new drug developed by Danish drugmaker ...

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Diabetes, Novo Nordisk AS

Fri Jun 06, 2008

The Scientist

Best Places to Work: Industry

The cafeteria at Infinity Pharmaceuticals is not your average greasy-spoon canteen, says Alex Constan, senior director of toxicology.

Comment?

Related Topix: Biotech, Black Entertainment, John Coltrane, Jazz, Billie Holliday, Medicine, Healthcare Industry, Woodland, CA

Wed Jun 04, 2008

Barron's

Diabetes Drugs Could Sweeten Shares

IT'S BEEN TWO YEARS since a drug maker has launched new diabetes meds in the US, as several promising treatments stumbled in development.

Comment?

Related Topix: Medicine, Diabetes, Health, Biotech, Healthcare Industry

Mon Jun 02, 2008

Rehab Management

Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008

ADA is one of the largest scientific meetings for endocrinologists and other health care professionals involved in diabetes research and the delivery of diabetes care.

Comment?

Related Topix: Law, Biotech, Diabetes, Health, Healthcare Industry

Fri May 30, 2008

Los Angeles Times

Weight-loss-maintenance drugs tested

Drug manufacturers are turning their attention to the maintenance problem. The San Diego company Amylin, for example, is testing a drug combination targeted at two of the hormonal signals driving weight regain.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Fri May 23, 2008

Blogging Stocks

Pre-market movers

Ford is down 1.4% on a brokerage downgrade after the car company cut earnings estimates.

Comment?

Related Topix: Apple, Startups, Computers, Apple Computer, Biotech, Medicine, Healthcare Industry, Financial Markets

Tue May 20, 2008

Fool.com

What Will Icahn Do With Amylin?

It's fun to peruse the Form 13-Fs of the most successful investors . Not only can you get investment ideas, but if you're an activist investor, you can get a sneak peek at the next company your favorite ...

Comment?

Related Topix: Biotech, AstraZeneca Group, Medicine, ImClone Systems, Healthcare Industry, Diabetes, Health

Sun May 18, 2008

Forbes.com

Icahn's On A Rampage

Where does 72-year old billionaire investor Carl Icahn get the energy? After prepping for a proxy fight this week with Yahoo! , it was revealed that Icahn bought 6.3 million shares of Amylin Pharmaceuticals in ... via Forbes.com

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, ImClone Systems

Fri May 16, 2008

Reuters

Icahn buys 6.3 mln shares of Amylin

Investor Carl Icahn bought 6.3 million shares of Amylin Pharmaceuticals in the first quarter of 2008 and also boosted his stake in Biogen Idec Inc during that time period, according to documents Icahn filed ... via Reuters

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Services

Fri May 09, 2008

MSN Money

Amylin spent $198,000 lobbying in the first quarter

Amylin Pharmaceuticals Inc. spent $198,000 lobbying the federal government on prescription drug issues in the first quarter of 2008. via MSN Money

Comment?

Related Topix: San Diego Metro, Biotech, Medicine, Healthcare Industry, Healthcare Law, Law

Wed May 07, 2008

Freshnews

Amylin Pharmaceuticals to Present at Bank of America Healthcare Conference

Amylin Pharmaceuticals, Inc. will be presenting at the Bank of America Healthcare Conference on Tuesday, May 13, 2008 at 10:00 a.m. PT in Las Vegas. via Freshnews

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Health, Diabetes

Mon May 05, 2008

Freshnews

Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study ...

Amylin Pharmaceuticals, Inc. today announced the initiation of a Phase 2B clinical study evaluating various dosing combinations of pramlintide, an analog of the natural hormone amylin, and recombinant human ... via Freshnews

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Wed Apr 30, 2008

Barron's

Amylin's Largest Holder Boosts Stake

Companies Featured in This Article: AMYLIN PHARMACEUTICALS, Eli Lilly, Ulta Salon Cosmetics & Fragrance, E*Trade Financial, Lexicon Pharmaceuticals, TRX, Medtox Scientific, RLI, Hill Rom Holdings, Great Lakes ... via Barron's

Comment?

Related Topix: Retail, Biotech, Medicine, Healthcare Industry

↑ Back to top

More Amylin Pharmaceuticals News

Archives

Read more articles in the Amylin Pharmaceuticals News Archives.

For up to the minute news, check out the Amylin Pharmaceuticals News Wire.

Want to add Amylin Pharmaceuticals News headlines to your web site? Get the widget here.

Amylin Pharmaceuticals News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Amylin Pharmaceuticals News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

Amylin Pharmaceuticals Photos

Topix Quick Poll

created by: Topix Pollster | May 15, 2008

Click on an option to vote

10,875

votes

  • 1 year
  • 2 years
  • 5 years
  • 10 years
  • 20 years
  • 50 years
  • 100+ years

Los Angeles Jobs